← Back to Search

Corticosteroid

ACTHAR Gel 40 units twice weekly for Sarcoidosis

Phase 2 & 3
Waitlist Available
Led By Marc A Judson, MD
Research Sponsored by Albany Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between week 0 and week 12.
Awards & highlights

Study Summary

ACTHAR gel has efficacy in the treatment of cutaneous sarcoidosis

Eligible Conditions
  • Sarcoidosis
  • Cutaneous Sarcoidosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between week 0 and week 12.
This trial's timeline: 3 weeks for screening, Varies for treatment, and between week 0 and week 12. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The change in SASI induration & erythema score.
Secondary outcome measures
DLQI
Extent of granulomatous inflammation in the biopsy lesion
Photographic change
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: ACTHAR Gel 80 units twice weeklyExperimental Treatment1 Intervention
ACTHAR gel at a dose of 80 units twice weekly sub cutaneous injections between Baseline and week 12.
Group II: ACTHAR Gel 40 units twice weeklyExperimental Treatment1 Intervention
ACTHAR Gel at a dose of 40 units twice weekly sub cutaneous injections between Baseline and week 12.

Find a Location

Who is running the clinical trial?

Albany Medical CollegeLead Sponsor
91 Previous Clinical Trials
11,487 Total Patients Enrolled
3 Trials studying Sarcoidosis
410 Patients Enrolled for Sarcoidosis
Marc A Judson, MDPrincipal InvestigatorAlbany Medical College
3 Previous Clinical Trials
46 Total Patients Enrolled
3 Trials studying Sarcoidosis
46 Patients Enrolled for Sarcoidosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
Marc A. Judson, MD 2015. "ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02348905.
All > Acth > Sarcoidosis
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top